Qing Zhou, Daniel Almquist, Byoung Chul Cho, Egbert F. Smit, Christian Caglevic, Ilkka Liikanen, Antonio Lugini, Rafal Dziadziuszko, Belen Rubio Viqueira, Steven Francis Powell, Gopal Kunta, Ozgur Ozyilkan, Sergii Prytuliak, Linlin Wang, Mustafa Erman, Diana Chen, Renata Eiras, Atsuko Ogino, Carlos Rojas. "KEYMAKER-U01J: Calderasib plus pembrolizumab with or without cetuximab as first-line treatment for advanced or metastatic nonsquamous non–small-cell lung cancer (NSCLC) with
                    <i>KRAS</i>
                    G12C mutations.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8679